Omnicuris Logo
Guardant and Zydus to Launch MCED Test in India

Guardant and Zydus to Launch MCED Test in India

Read More
Full Text
2 weeks back
Guardant Health and Zydus Lifesciences have partnered to introduce a transformative multi-cancer detection test in India. This innovative tool aims to address the rising cancer burden through early detection. Moreover, the liquid biopsy technology identifies tumor DNA fragments in the blood. Therefore, it provides a minimally invasive alternative to traditional tissue-based diagnostic procedures.

The Clinical Utility of Multi-cancer Detection Test Technology


The 'Shield' test recently received FDA approval in the United States for colorectal cancer screening. However, the Indian rollout will cover a broader panel including lung, breast, and gastric cancers. Clinical data indicates that the test has an 83% sensitivity for colorectal cancer. Furthermore, it detects approximately 100% of stage II to IV colorectal malignancies. Consequently, clinicians can utilize this blood-based screening to identify tumors before symptoms appear.

Addressing Diagnostic Gaps in the Indian Market


India currently reports that nearly 70% of cancer cases are diagnosed at advanced stages. This delay often leads to poorer clinical outcomes and significantly higher treatment expenses. Additionally, screening rates for common cancers remain exceptionally low across the country. Guardant Health is currently negotiating with ten major hospital chains and wellness centers for the rollout. Although the US price is around Rs 1.4 lakh, local pricing is being carefully developed with Zydus.

Future Outlook for Precision Oncology


Early detection through genomic profiling could improve survival rates by up to ten times. By identifying mutations through simple blood draws, healthcare providers can personalize treatment paths earlier. Finally, the collaboration between Guardant and Zydus represents a strategic shift toward preventive oncology in India.

Frequently Asked Questions


Q1: Which specific cancers can the multi-cancer detection test identify?


The panel includes gastric, esophageal, liver, colorectal, ovarian, lung, pancreatic, bladder, breast, and prostate cancers.


Q2: Is this blood test a replacement for a traditional colonoscopy?


No, it is a screening tool. Patients who receive a positive result from the blood test must follow up with a diagnostic colonoscopy for confirmation.



Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.


References



  1. Guardant Health to launch blood-based cancer test in India with ZydusLifesciences - ETHealthworld

  2. Shield™ Colorectal Cancer Screening Blood Test - Guardant Health Official Site

  3. FDA Approves Blood Test for Colorectal Cancer Screening - National Cancer Institute

Login to continue

More from MedShots Daily

Guardant and Zydus to Launch MCED Test in India
Guardant and Zydus to Launch MCED Test in India

Guardant Health and Zydus Lifesciences are launching a blood-based multi-cancer detection test in India to improve early diagnosis and patient survival rate...

2 weeks back

Read More
Full Text
Escalating Cancer Mortality in ILD Patients: A 21-Year Population Study
Escalating Cancer Mortality in ILD Patients: A 21-Year Population Study

A comprehensive analysis of over 500,000 cases shows that cancer-related deaths are rising in ILD patients, contradicting general national trends....

Today

Read More
Full Text
Bridging Gaps in the Perinatal SUD Continuum: From Screening to Treatment Engagement
Bridging Gaps in the Perinatal SUD Continuum: From Screening to Treatment Engagement

New research shows a critical disconnect in the perinatal SUD continuum, where screening rarely leads to treatment without proactive provider-led conversati...

Today

Read More
Full Text
Preoperative Anemia and Iron Deficiency in Cardiac Surgery: Diagnosis and Impact
Preoperative Anemia and Iron Deficiency in Cardiac Surgery: Diagnosis and Impact

A summary of the Inter-American Society of Cardiology position statement on diagnosing preoperative anemia and iron deficiency in cardiac surgery patients....

Today

Read More
Full Text
Direction-Specific Balance Training for Chronic Ankle Instability in Athletes
Direction-Specific Balance Training for Chronic Ankle Instability in Athletes

A meta-analysis reveals that balance training significantly improves direction-specific dynamic balance in athletes with chronic ankle instability (CAI)....

Today

Read More
Full Text
Defining Remission in Long-Term Conditions Using EHR Data
Defining Remission in Long-Term Conditions Using EHR Data

A scoping review of 91 studies explores how Electronic Health Records (EHRs) define remission across 12 long-term conditions, emphasizing standardization....

Today

Read More
Full Text
Showing Page 1 of 1(5 items total)
Go to Page

"Wherever the art of Medicine is loved, there is also a love of Humanity."

— Hippocrates

made with❤️byOmnicuris